Avastin (bevacizumab)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   December 2015 ADVERSE REACTIONS Clinical Trial Experience Renal Injury A retrospective analysis across clinical...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts